Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $596.96 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sun Pharmaceutical Industries Inc. | $109.13 | 6 | $0 (2020) |
| AbbVie Inc. | $92.84 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $88.69 | 5 | $0 (2023) |
| NotalVision | $77.13 | 1 | $0 (2017) |
| Shire North American Group Inc | $55.55 | 3 | $0 (2018) |
| Johnson & Johnson Vision Care, Inc. | $55.54 | 1 | $0 (2017) |
| Carl Zeiss Meditec USA, Inc. | $26.11 | 1 | $0 (2023) |
| Biogen, Inc. | $22.47 | 1 | $0 (2022) |
| Alcon Vision LLC | $21.22 | 1 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $14.94 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $136.30 | 7 | AbbVie Inc. ($75.89) |
| 2022 | $66.48 | 4 | Biogen, Inc. ($22.47) |
| 2021 | $21.52 | 1 | Novartis Pharmaceuticals Corporation ($21.52) |
| 2020 | $38.42 | 2 | Sun Pharmaceutical Industries Inc. ($20.28) |
| 2019 | $47.23 | 3 | Novartis Pharmaceuticals Corporation ($21.26) |
| 2018 | $111.70 | 6 | Sun Pharmaceutical Industries Inc. ($69.91) |
| 2017 | $175.31 | 5 | NotalVision ($77.13) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: EYE CARE | ||||||
| 07/17/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Ophthalmology | ||||||
| 06/21/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: EYE CARE | ||||||
| 05/19/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: EYE CARE | ||||||
| 05/02/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Ophthalmology | ||||||
| 04/03/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: EYE CARE | ||||||
| 02/09/2023 | Carl Zeiss Meditec USA, Inc. | IOLMaster 700 (Device) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Optical Biometer | ||||||
| 07/18/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $22.47 | General |
| 07/13/2022 | Thea Pharma Inc. | — | Food and Beverage | In-kind items and services | $12.37 | General |
| 05/18/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: GLAUCOMA | ||||||
| 05/10/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/08/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/13/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/06/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: Ophthalmology | ||||||
| 10/03/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/06/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/17/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Glaucoma | ||||||
| 12/18/2018 | Sun Pharmaceutical Industries Inc. | XELPROS (latanoprost ophthalmic emulsion) 0.005% (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Ophthalmology | ||||||
| 11/28/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: OPTHALMICS | ||||||
| 09/27/2018 | Sun Pharmaceutical Industries Inc. | BromSite (bromfenac ophthalmic solution) 0.075% (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Ophthalmology | ||||||
| 05/15/2018 | Sun Pharmaceutical Industries Inc. | BromSite (bromfenac ophthalmic solution) 0.075% (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Ophthalmology | ||||||
| 05/01/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: OPTHALMICS | ||||||
| 02/13/2018 | Sun Pharmaceutical Industries Inc. | BromSite (bromfenac ophthalmic solution) 0.075% (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Ophthalmology | ||||||
| 09/14/2017 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $55.54 | General |
| Category: Soft Contact Lenses | ||||||
| 08/24/2017 | Sun Pharmaceutical Industries Inc. | Bromsite (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 118 | 121 | $18,130 | $6,569 |
| 2022 | 7 | 364 | 378 | $62,780 | $22,043 |
| 2021 | 10 | 541 | 578 | $96,310 | $36,839 |
| 2020 | 6 | 254 | 267 | $47,425 | $14,489 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 42 | $8,610 | $3,581 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 28 | $3,920 | $1,463 | 37.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 11 | 11 | $1,650 | $479.31 | 29.0% |
| 92134 | Imaging of retina | Office | 2023 | 16 | 16 | $1,680 | $424.45 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,170 | $413.10 | 35.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 11 | 11 | $1,100 | $207.52 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 141 | $28,905 | $10,001 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 82 | $11,480 | $4,626 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $8,990 | $3,342 | 37.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 33 | $2,970 | $1,423 | 47.9% |
| 92134 | Imaging of retina | Office | 2022 | 47 | 47 | $4,935 | $1,179 | 23.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 17 | 18 | $2,700 | $767.87 | 28.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 27 | 28 | $2,800 | $703.57 | 25.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 188 | $38,540 | $15,468 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 118 | $16,520 | $7,976 | 48.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 43 | 43 | $10,320 | $3,300 | 32.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 54 | 64 | $5,760 | $2,607 | 45.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $6,200 | $1,863 | 30.1% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 60 | 61 | $6,405 | $1,642 | 25.6% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 22 | 23 | $3,450 | $1,030 | 29.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 11 | 11 | $3,135 | $1,014 | 32.3% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 35 | 36 | $3,600 | $973.92 | 27.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 14 | 14 | $2,380 | $964.73 | 40.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 118 | 122 | $25,010 | $7,620 | 30.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 58 | 66 | $9,240 | $3,047 | 33.0% |
About Dr. Franklin Crissy, O.D
Dr. Franklin Crissy, O.D is a Optometrist healthcare provider based in Bellingham, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932289188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Franklin Crissy, O.D has received a total of $596.96 in payments from pharmaceutical and medical device companies, with $136.30 received in 2023. These payments were reported across 28 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($596.96).
As a Medicare-enrolled provider, Crissy has provided services to 1,277 Medicare beneficiaries, totaling 1,344 services with total Medicare billing of $79,940. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Bellingham, WA
- Active Since 10/16/2006
- Last Updated 02/24/2011
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1932289188
Products in Payments
- XIIDRA (Drug) $144.24
- DURYSTA (Drug) $92.84
- ForeseeHome (Device) $77.13
- Acuvue (Device) $55.54
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $52.17
- IOLMaster 700 (Device) $26.11
- Rocklatan (Drug) $21.22
- CEQUA (Drug) $20.28
- Bromsite (Drug) $18.94
- XELPROS (latanoprost ophthalmic emulsion) 0.005% (Drug) $17.74
- VYZULTA (Drug) $14.94
- Rhopressa (Drug) $11.03
- InflammaDry (Device) $9.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Bellingham
Dr. Spencer Young, O.d, O.D
Optometrist — Payments: $9,483
Monica Miller
Optometrist — Payments: $7,647
Dr. Mark Aginsky, O.d, O.D
Optometrist — Payments: $7,495
Dr. Darlene Anker, O.d, O.D
Optometrist — Payments: $3,907
Dr. Riya Paranthan, O.d, O.D
Optometrist — Payments: $3,757
Bryan Redick, Od, OD
Optometrist — Payments: $3,321